Publikationen von Soni Savai Pullamsetti
Alle Typen
Zeitschriftenartikel (74)
2021
Zeitschriftenartikel
178 (1), S. 54 - 71 (2021)
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy. BRITISH JOURNAL OF PHARMACOLOGY 2020
Zeitschriftenartikel
12 (12), 3528 (2020)
Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis. CANCERS
Zeitschriftenartikel
202 (10), S. 1445 - 1457 (2020)
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFR beta. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Zeitschriftenartikel
10 (4), 2045894020947283 (2020)
Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats. PULMONARY CIRCULATION
Zeitschriftenartikel
29 (157), 200134 (2020)
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment. EUROPEAN RESPIRATORY REVIEW
Zeitschriftenartikel
52 (1), S. 9 - + (2020)
TGF-beta Signaling Promotes Tissue Formation during Cardiac Valve Regeneration in Adult Zebrafish. DEVELOPMENTAL CELL
Zeitschriftenartikel
10 (1), 12864 (2020)
Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension. SCIENTIFIC REPORTS
Zeitschriftenartikel
80 (19), S. 4199 - 4211 (2020)
Metastasis-Associated Protein 2 Represses NF-kappa B to Reduce Lung Tumor Growth and Inflammation. CANCER RESEARCH
Zeitschriftenartikel
130 (11), S. 5638 - 5651 (2020)
Hypoxia-inducible factor signaling in pulmonary hypertension. JOURNAL OF CLINICAL INVESTIGATION
Zeitschriftenartikel
175, S. 53 - 65 (2020)
Assaying epigenome functions of PRMTs and their substrates. METHODS
Zeitschriftenartikel
130 (7), S. 3560 - 3575 (2020)
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. JOURNAL OF CLINICAL INVESTIGATION
Zeitschriftenartikel
6 (23), eaaz6105 (2020)
Reprogramming of tumor-associated macrophages by targeting beta-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer. SCIENCE ADVANCES
Zeitschriftenartikel
11 (1), 1185 (2020)
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension. NATURE COMMUNICATIONS
Zeitschriftenartikel
9 (8), 1755 (2020)
Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. CELLS
Zeitschriftenartikel
80 (20), S. 4414 - 4425 (2020)
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma. CANCER RESEARCH 2019
Zeitschriftenartikel
Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction. BRITISH JOURNAL OF PHARMACOLOGY (2019)
Zeitschriftenartikel
10, 2130 (2019)
A RASSF1A-HIF1 alpha loop drives Warburg effect in cancer and pulmonary hypertension. NATURE COMMUNICATIONS
Zeitschriftenartikel
597 (4), S. 1103 - 1119 (2019)
Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension. JOURNAL OF PHYSIOLOGY-LONDON
Zeitschriftenartikel
53 (1), 1801887 (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. EUROPEAN RESPIRATORY JOURNAL
Zeitschriftenartikel
10, 2229 (2019)
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis. NATURE COMMUNICATIONS